Azathloprise in refractory sprue. Results from a prospective open-label study

Azathioprine in refractory sprue: results from a prospective, open-label study

The American Journal of Gastroenterology ◽

10.1016/s0002-9270(02)04387-3 ◽

2002 ◽

Vol 97 (10) ◽

pp. 2595-2602 ◽

Cited By ~ 30

Author(s):

E Mauriño

Keyword(s):

Open Label ◽

Open Label Study ◽

Label Study ◽

Azathloprise in refractory sprue. Results from a prospective open-label study

Gastroenterology ◽

10.1016/s0016-5085(08)81948-8 ◽

2001 ◽

Vol 120 (5) ◽

pp. A392 ◽

Cited By ~ 1

Author(s):

Sonia I. Niveloni ◽

Alejandra Chernavsky ◽

Silvia C. Pedreira ◽

Roberto M. Mazure ◽

Horacio Vazquez ◽

...

Keyword(s):

Open Label ◽

Open Label Study ◽

Label Study ◽

Azathioprine in refractory sprue: results from a prospective, open-label study

The American Journal of Gastroenterology ◽

10.1111/j.1572-0241.2002.06029.x ◽

2002 ◽

Vol 97 (10) ◽

pp. 2595-2602 ◽

Cited By ~ 11

Author(s):

Eduardo Maurino ◽

Sonia Niveloni ◽

Alejandra Chernavsky ◽

Silvia Pedreira ◽

Roberto Mazure ◽

...

Keyword(s):

Open Label ◽

Open Label Study ◽

Label Study ◽

Normalization of urinary cortisol with the potent 11[beta]-hydroxylase inhibitor LCI699 in patients with Cushing's disease: 22-week, multicentre, open-label study

Endocrine Abstracts ◽

10.1530/endoabs.35.oc8.4 ◽

2014 ◽

Author(s):

Beverly Biller ◽

Jacques Young ◽

Amir Hamrahian ◽

Maria Fleseriu ◽

Mark Molitch ◽

...

Keyword(s):

Cushing’S Disease ◽

Cushing's Disease ◽

Urinary Cortisol ◽

Open Label ◽

Open Label Study ◽

Biochemical control was sustained with long-acting pasireotide in patients with uncontrolled acromegaly over continued treatment with first-generation somatostatin analogues (SSAs): Results from the extension of phase 3b, open-label study

Endocrine Abstracts ◽

10.1530/endoabs.63.gp57 ◽

2019 ◽

Author(s):

Monica Gadelha ◽

Annamaria Colao ◽

Marie Bex ◽

Rishav Mukherjee ◽

Catherine Bourad ◽

...

Keyword(s):

First Generation ◽

Somatostatin Analogues ◽

Biochemical Control ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Long Acting

Weighing the Evidence: Can We Believe an Open-Label Study?

AAP Grand Rounds ◽

10.1542/gr.16-4-39 ◽

2006 ◽

Vol 16 (4) ◽

pp. 39-39

Author(s):

B. L. Wiedermann

Keyword(s):

Open Label ◽

Open Label Study ◽

Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Axillary Hyperhidrosis

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.94 ◽

2017 ◽

Vol 1 ◽

pp. s95 ◽

Cited By ~ 1

Author(s):

Dee Anna Glaser ◽

Adelaide A Hebert ◽

Alexander Nast ◽

William P Werschler ◽

Stephen Shideler ◽

...

Keyword(s):

Axillary Hyperhidrosis ◽

Open Label ◽

Open Label Study ◽

Abstract Not AvailableDisclosure: Study supported by Dermira.

Nefazodone Treatment of Adolescent Depression: An Open-Label Study of Response and Biochemistry

Annals of Clinical Psychiatry ◽

10.3109/10401230009147095 ◽

2000 ◽

Vol 12 (2) ◽

pp. 97-100 ◽

Cited By ~ 8

Author(s):

Paul Goodnick ◽

Cecilia Jorge ◽

Thomas Hunter ◽

Adarsh Kumar

Keyword(s):

Adolescent Depression ◽

Open Label ◽

Open Label Study ◽

Treatment of Somatization Disorder With Nefazodone: A Prospective, Open-Label Study

Annals of Clinical Psychiatry ◽

10.3109/10401230109148962 ◽

2001 ◽

Vol 13 (3) ◽

pp. 153-158 ◽

Cited By ~ 14

Author(s):

Matthew Menza ◽

Marc Lauritano ◽

Lesley Allen ◽

Melissa Warman ◽

Frank Ostella ◽

...

Keyword(s):

Somatization Disorder ◽

Open Label ◽

Open Label Study ◽

Phase 1 First Time in Humans (FTIH), Open Label Study of GSK3745417 Administered to Subjects With Advanced Solid Tumors

Case Medical Research ◽

10.31525/ct1-nct03843359 ◽

2000 ◽

Author(s):

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

First Time